Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bioasis Technologies Inc.
Bullboard Posts
User Avatar Image
(2146)
•••
Comment by jdstoxon Aug 01, 2017 3:28pm
245 Views
Post# 26534875

RE:RE:RE:RE:RE:financials

RE:RE:RE:RE:RE:financialsI would think, drjekyl, that GCP (Gateway Credit Partners) would become news if and when biOasis arranges non-dilutive financing and if GCP has had a part in getting that done.

Until then, I'm surprised they even get a mention in the MD&A.

You can act better than you have, drjekyl. There's no need for you continue your denigrating behaviour. You'll likely make money on this, jekyl, and lots of it. It'll be rather difficult for you to call the rest of us stupid when we all have $20 or more per share in our pockets and we called it while you argued against us.

Time to move on, jekyl. all of you.

jdstox

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities